Structure, function and carcinogenicity of metabolites of methylated and non-methylated polycyclic aromatic hydrocarbons: a comprehensive review
Authors:
- 19 February 2016
- journal article
- review article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 26 (3) , 151-179
Abstract
The Unified Theory of PAH Carcinogenicity accommodates the activities of methylated and non-methylated polycyclic aromatic hydrocarbons (PAHs) and states that substitution of methyl groups on meso-methyl substituted PAHs with hydroxy, acetoxy, chloride, bromide or sulfuric acid ester groups imparts potent cancer producing properties. It incorporates specific predictions from past researchers on the mechanism of carcinogenesis by methyl-substituted hydrocarbons, including (1) requirement for metabolism to an ArCH2X type structure where X is a good leaving group and (2) biological substitution of a meso-methyl group at the most reactive center in non-methylated hydrocarbons. The Theory incorporates strong inferences of Fieser: (1) The mechanism of carcinogenesis involves a specific metabolic substitution of a hydrocarbon at its most reactive center and (2) Metabolic elimination of a carcinogen is a detoxifying process competitive with that of carcinogenesis and occurring by a different mechanism. According to this outlook, chemical or biochemical substitution of a methyl group at the reactive meso-position of non-methylated hydrocarbons is the first step in the mechanism of carcinogenesis for most, if not all, PAHs and the most potent metabolites of PAHs are to be found among the meso methyl-substituted hydrocarbons. Some PAHs and their known or potential metabolites and closely related compounds have been tested in rats for production of sarcomas at the site of subcutaneous injection and the results strongly support the specific predictions of the Unified Theory.Keywords
This publication has 170 references indexed in Scilit:
- Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissueInternational Journal of Cancer, 2005
- Comparative Carcinogenicity of Picene and Dibenz[a,h]anthracene in the RatBiochemical and Biophysical Research Communications, 2002
- The strong hepatocarcinogenicity of the electrophilic and mutagenic metabolite 6-sulfooxymethylbenzo[α]pyrene and its formation of benzylic dna adducts in the livers of infant male B6C3F1 miceBiochemical and Biophysical Research Communications, 1990
- Excision of 7-bromomethylbenz[a]anthracene-DNA adducts in replicating mammalian cellsBiochemistry, 1977
- The N-Methylformanilide Synthesis of AldehydesJournal of the American Chemical Society, 1942
- Synthesis of 4',8'-Dihydroxy-1,2,5,6-dibenzanthracene and its Relation to Products of Metabolism of the HydrocarbonJournal of the American Chemical Society, 1940
- Sulfhydryl and Cysteine Derivatives of 1,2-Benzanthracene, 10-Methyl-1,2-benzanthracene and 3,4-BenzpyreneJournal of the American Chemical Society, 1940
- The Synthesis of 1,2-Benzanthracene Derivatives Related to 3,4-BenzpyreneJournal of the American Chemical Society, 1937
- The Synthesis of 1,2-Benzanthracene Derivatives Related to CholanthreneJournal of the American Chemical Society, 1936
- The Choleic Acids of Certain Carcinogenic HydrocarbonsJournal of the American Chemical Society, 1935